Affordable Access

Sequential BCG and electromotive mitomycin versus BCG alone for high-risk superficial bladder cancer: a randomised controlled trial.

Authors
  • Di Stasi, Savino M
  • Giannantoni, Antonella
  • Giurioli, Arcangelo
  • Valenti, Marco
  • Zampa, Germano
  • Storti, Luigi
  • Attisani, Francesco
  • De Carolis, Andrea
  • Capelli, Giovanni
  • Vespasiani, Giuseppe
  • Stephen, Robert L
Type
Published Article
Journal
The Lancet Oncology
Publisher
Elsevier
Publication Date
Jan 01, 2006
Volume
7
Issue
1
Pages
43–51
Identifiers
PMID: 16389183
Source
Medline
License
Unknown

Abstract

BCG-induced inflammation might increase the permeability of the bladder mucosa such that mitomycin can reach the target tissue more easily and exert its anticancer effect.

Report this publication

Statistics

Seen <100 times